Cite

HARVARD Citation

    Terenzi, R. et al. (n.d.). SAT0150 Soluble FAS/FASL levels in rheumatoid arthritis patients treated with infliximab and adalimumab. Annals of the rheumatic diseases. p. 522. [Online]. 
  
Back to record